oMeds
All answers
Answer · hormone optimization

Which pathway addresses chronic fatigue?

Short answer

Fatigue is screened against sleep, thyroid, iron, B12, vitamin D, glucose, and mood. Confirmed deficits are repleted. Confirmed low testosterone routes to TRT; peri/menopausal patterns to BHRT; longevity-axis candidates to NAD+.

Reviewed by Dr. Laura PurdyJune 3, 2026

Full answer

Fatigue is the most common reason patients seek optimization care. The screen pairs sleep history (with apnea risk), TSH/free T4, ferritin and iron studies, B12, vitamin D, fasting glucose, HbA1c, hs-CRP, and mood. Confirmed deficits are repleted first because hormone optimization cannot substitute for reversible drivers. Men with confirmed low testosterone are evaluated for TRT. Peri/menopausal women are evaluated for BHRT. Patients prioritizing cellular and longevity-axis goals can add NAD+. Every plan is synchronous-video reviewed.

Educational. Not a substitute for individualized provider review.

References & sources